Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592942 | SCV000705647 | uncertain significance | not provided | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000592942 | SCV001057466 | benign | not provided | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000592942 | SCV001752149 | likely benign | not provided | 2020-08-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835867 | SCV002086258 | likely benign | Usher syndrome type 1 | 2020-05-13 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004543359 | SCV004776773 | likely benign | CDH23-related disorder | 2019-11-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |